Managing Nighttime Seizures with Lamotrigine and Valproate
For patients experiencing nighttime seizures while on lamotrigine (Lamictal) and valproate (Depakote), adding levetiracetam as a third agent is recommended due to its favorable efficacy and side effect profile for refractory seizures. 1
Evaluation of Current Therapy
Before adding a third medication, consider the following:
Dosage optimization: Ensure current medications are at therapeutic levels
- Lamotrigine (250mg): Therapeutic range is typically 3-14 μg/mL
- Valproate (1000mg): Therapeutic range is typically 50-100 μg/mL
Timing adjustment: Consider shifting more of the valproate dose to evening to improve nighttime seizure control
Adherence assessment: Confirm consistent medication intake, as missed doses can trigger breakthrough seizures
Adding a Third Agent
If seizures persist despite optimized doses of lamotrigine and valproate, adding a third agent is appropriate:
Preferred Option: Levetiracetam
- Starting dose: 500mg at bedtime
- Titration: Increase by 500mg every 1-2 weeks as needed
- Target dose: 1000-2000mg daily (with higher proportion in evening)
- Advantages:
Alternative Options:
Zonisamide:
- Consider if levetiracetam is not tolerated
- However, research shows lamotrigine is superior to zonisamide for seizure control 2
Ethosuximide:
Lifestyle Modifications
In addition to medication adjustments:
- Sleep hygiene: Establish consistent sleep schedule
- Avoid triggers: Minimize alcohol, caffeine, and sleep deprivation
- Safety measures: Consider using bed alarms or monitoring devices for nighttime seizures
- Positioning: Sleep in recovery position (on side) to prevent airway complications during seizures
Monitoring Plan
- EEG monitoring: Consider overnight EEG to characterize seizures, especially if mental status changes occur 5
- Laboratory monitoring:
- Baseline CBC, LFTs, valproate level, renal function, electrolytes
- Regular monitoring of drug levels every 3 months
- More frequent monitoring during medication adjustments 1
Important Considerations
- Avoid prophylactic anticonvulsants without clear evidence of seizures 5
- Women of childbearing potential: Note that valproate carries significant teratogenicity risks; levetiracetam is preferred in this population 1
- Medication interactions: Monitor closely as you're on multiple antiepileptic drugs
- Adverse effects to watch for:
- Lamotrigine: Rash (potentially serious), dizziness, headache
- Valproate: Gastrointestinal disturbances, tremor, weight gain, hair loss
- Levetiracetam: Irritability, mood changes, somnolence 1
If seizures remain uncontrolled despite these interventions, referral to a comprehensive epilepsy center for video-EEG monitoring and consideration of surgical options may be warranted.